Fosfomycin Trometamol versus Netiltnicin in Pediatric Urinary Tract Infections

2015 ◽  
pp. 171-177 ◽  
Author(s):  
L. Peratoner ◽  
A. Corrias ◽  
R. Tumbarello ◽  
D. Bassetti ◽  
L. A. Varese ◽  
...  
2019 ◽  
Vol 103 (6) ◽  
pp. 1272-1276 ◽  
Author(s):  
Thijs ten Doesschate ◽  
Henri van Werkhoven ◽  
Sabine Meijvis ◽  
Janneke Stalenhoef ◽  
Arjan van Zuilen ◽  
...  

2021 ◽  
Vol 14 (1) ◽  
pp. 86-91
Author(s):  
Paweł Miotła

Urinary tract infections are one of the most common diseases among women. At least 50% of women will develop at least one of urinary tract infection episode during life-time. It should be also underlined that more than one-fourth of them will also develop recurrence within the half year following the initial infection and therapy. The empirical treatment of urinary tract infections should include susceptibility data based on local antimicrobial resistance rates. The effective initial treatment can be considered as an effective preventive strategy of the rapidly increasing bacterial resistance to antibiotics. Fosfomycin trometamol is a safe and highly effective antimicrobial drug which can be used in a single dose in the treatment of uncomplicated urinary tract infections.


2018 ◽  
Vol 30 (5) ◽  
pp. 290-295 ◽  
Author(s):  
Tommaso Cai ◽  
Andrea Cocci ◽  
Paolo Verze ◽  
Michele Rizzo ◽  
Alessandro Palmieri ◽  
...  

2015 ◽  
pp. 316-318
Author(s):  
Francesco P. Selvaggi ◽  
Antonio Traficante ◽  
Michele Battaglia ◽  
Pasquale Ditonno ◽  
Vito Di Lorenzo

Sign in / Sign up

Export Citation Format

Share Document